Publications by authors named "Tamami Abe"

Claim this Profile
O
Obesity Decreases Liver-Related Death in Patients With Cirrhosis: A Retrospective Propensity Score-Matched Study.
Kei Endo, Keisuke Kakisaka, Tamami Abe, Hiroaki Abe, Ippeki Nakaya, Takuya Watanabe

Hepatol Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Model to Predict Survival Time in Patients With Hepatocellular Carcinoma With BCLC Advanced Stage.
Masashi Ninomiya, Mio Tsuruoka, Jun Inoue, Atsushi Hiraoka, Akitoshi Sano, Kengo Watanabe, Tamami Abe, Kazumichi Abe, Nobukazu Tanabe

Cancer Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey.
Takao Miwa, Mio Tsuruoka, Hajime Ueda, Tamami Abe, Hiroki Inada

J Gastroenterol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune hepatitis following transition from prednisolone to thrombopoietin receptor agonist therapy in immune thrombocytopenic purpura: A clinical precaution.
Kaname Inarimori, Keisuke Kakisaka, Takuya Watanabe, Tokio Sasaki, Yudai Fujiwara, Tamami Abe

Hepatol Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicenter study.
Takashi Nishimura, Toshifumi Tada, Tomoyuki Akita, Reiichiro Kondo, Yasuaki Suzuki, Tamami Abe

J Gastroenterol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual pathogenic mechanisms in lysinuric protein intolerance: Interplay between hyperammonemia and cellular metabolic dysregulation in astrocyte injury.
Keisuke Kakisaka, Takuro Sato, Yasunori Wada, Hiroaki Abe, Shizuka Abe, Takuya Watanabe, Tamami Abe

Mol Genet Metab· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Cabozantinib Dosing in Unresectable Hepatocellular Carcinoma of 7-on/7-off Regimen.
Yudai Fujiwara, Hidekatsu Kuroda, Tamami Abe, Kei Endo, Takayoshi Oikawa, Kazumichi Abe, Nobukazu Tanabe, Takuya Watanabe

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices.
Hidekatsu Kuroda, Tamami Abe, Naohisa Kamiyama, Takuma Oguri, Asami Ito, Takuya Watanabe, Hiroaki Abe

J Gastroenterol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices.
Hidekatsu Kuroda, Tamami Abe, Naohisa Kamiyama, Takuma Oguri, Asami Ito, Takuya Watanabe, Hiroaki Abe

J Gastroenterol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of shear wave elastography and attenuation imaging for predicting life-threatening event in patients with metabolic dysfunction-associated steatotic liver disease.
Yudai Fujiwara, Hidekatsu Kuroda, Tamami Abe, Tomoaki Nagasawa, Ippeki Nakaya, Takuya Watanabe

Sci Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microwave ablation single-needle radiofrequency ablation for the treatment of HCC up to 4 cm: A randomized-controlled trial.
Katsutoshi Sugimoto, Kento Imajo, Hidekatsu Kuroda, Go Murohisa, Kazue Shiozawa, Tamami Abe

JHEP Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Grip strength complements performance status in assessing general condition in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.
Kei Endo, Keisuke Kakisaka, Tamami Abe, Kenji Yusa, Ippeki Nakaya, Takuya Watanabe, Hiroaki Abe

Hepatol Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Clinical Outcomes of Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma: A Real-World Comparison with First-Line or Later-Line Treatment.
Yudai Fujiwara, Hidekatsu Kuroda, Tamami Abe, Keisuke Kakisaka, Ippeki Nakaya, Takuya Watanabe

Drugs Real World Outcomes· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index of 23 or greater is relevant to hepatic steatosis and fibrosis in patients with harmful alcohol use.
Keisuke Kakisaka, Takuya Watanabe, Yuichi Yoshida, Hiroaki Abe, Kenji Yusa, Tamami Abe

Hepatol Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positive impact of obesity on the prognosis of liver cirrhosis.
Kei Endo, Keisuke Kakisaka, Tamami Abe, Kenji Yusa, Ippeki Nakaya, Takuya Watanabe

J Gastroenterol Hepatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune Hepatitis Complicated by Undiagnosed Factor VII Deficiency: A Pitfall of Coagulopathy.
Kotaro Kishimoto, Keisuke Kakisaka, Tamami Abe, Asami Ito, Kenji Yusa

Intern Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low liver reserve is a risk factor for acute pancreatitis in patients with acute liver failure.
Keisuke Kakisaka, Tokio Sasaki, Ippeki Nakaya, Takuya Watanabe, Hiroaki Abe, Tamami Abe

Hepatol Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor-associated colitis in unresectable hepatocellular carcinoma: two cases of early onset after treatment with durvalumab plus tremelimumab.
Hiroaki Abe, Kei Endo, Hidekatsu Kuroda, Takayoshi Oikawa, Tamami Abe

Clin J Gastroenterol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroprevalence and incidence of hepatitis E virus infection in the general population of Iwate prefecture, Japan: A retrospective cohort study.
Yuichi Yoshida, Asami Ito, Hisashi Eto, Akiko Suzuki, Tamami Abe

Hepatol Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis.
Hidekatsu Kuroda, Takuma Oguri, Naohisa Kamiyama, Hidenori Toyoda, Satoshi Yasuda, Tamami Abe

Radiology· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coincidental items in the definition of metabolic dysfunction-associated fatty liver are useful in identifying patients having significant fibrosis with fatty liver.
Keisuke Kakisaka, Hidekatsu Kuroda, Tamami Abe, Ippeki Nakaya, Takuya Watanabe

Hepatol Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitor-Related Pneumonia in Unresectable Hepatocellular Carcinoma: Two Fatal Cases under Atezolizumab plus Bevacizumab.
Kei Endo, Hidekatsu Kuroda, Takayoshi Oikawa, Yuma Ito, Tamami Abe

Liver Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shear wave dispersion to assess liver disease progression in Fontan-associated liver disease.
Tomoaki Nagasawa, Hidekatsu Kuroda, Tamami Abe, Hirofumi Saiki, Yasuhiro Takikawa

PLoS One· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Concept of Indeterminable NASH Inducted by Preoperative Diet and Metabolic Surgery: Analyses of Histopathological and Clinical Features.
Akira Sasaki, Akira Umemura, Kazuyuki Ishida, Naoto Takahashi, Haruka Nikai, Tamami Abe

Biomedicines· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease.
Hidekatsu Kuroda, Tamami Abe, Yudai Fujiwara, Tomoaki Nagasawa, Yasuhiro Takikawa

J Med Ultrason (2001)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis